Citations

Mayo Clinic

Showing 10 of 108585 citations.

Staff Nurse Decisional Involvement in the United States and Turkey
Uğur, Esra , Scherb, Cindy A., Specht, Janet, Şen, Sevim , Lazzara, Lydia K.

Western Journal of Nursing Research | November 30, 2016 | Volume: 39 | Issue: 12 | Pages: 1589-1605

10.1177/0193945916679630 | PMID 27903828 Get It

The purpose of this descriptive comparative study is to compare the levels of decisional involvement of staff nurses between one Midwestern health care system in the United States with a nongovernmental University hospital in Turkey. The Decisional Involvement Scale was used for data collection. U.S. ( n = 163) and Turkey ( n = 50) staff nurses were included in the study. Both samples preferred more decisional involvement than they currently experienced. However, Turkish nurses experienced and preferred lower levels of decisional involvement than the U.S. sample. Shared governance structures may be a strategy used to enhance staff nurse decisional involvement.
Clinically Meaningful Use of Blood Tumor Markers in Oncology
Holdenrieder, S , Pagliaro, Lance C. , Morgenstern, David , Dayyani, Farshid , Holdenrieder, Stefan , Dayyani, Farshid

BioMed Research International | November 30, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-10

10.1155/2016/9795269 | PMID 28042579 Get It

Before the introduction of modern imaging techniques and the recent developments in molecular diagnosis, tumor markers (TMs) were among the few available diagnostic tools for the management of cancer patients. Easily obtained from serum or plasma samples, TMs are minimally invasive and convenient, and the associated costs are low. Single TMs were traditionally used but these have come under scrutiny due to their low sensitivity and specificity when used, for example, in a screening setting. However, recent research has shown superior performance using a combination of multiple TMs as a panel for assessment, or as part of validated algorithms that also incorporate other clinical factors. In addition, newer TMs have been discovered that have an increased sensitivity and specificity profile for defined malignancies. The aim of this review is to provide a concise overview of the appropriate uses of both traditional and newer TMs and their roles in diagnosis, prognosis, and the monitoring of patients in current clinical practice. We also look at the future direction of TMs and their integration with other diagnostic modalities and other emerging serum based biomarkers, such as circulating nucleic acids, to ultimately advance diagnostic performance and improve patient management.
Academic Achievement in Adults with a History of Childhood Attention-Deficit/Hyperactivity Disorder: A Population-Based Prospective Study
Voigt, Robert G. , Katusic, Slavica K., Colligan, Robert C., Killian, Jill M. , Weaver, Amy L. , Barbaresi, William J.

Journal of Developmental & Behavioral Pediatrics | November 30, 2016 | Volume: 38 | Issue: 1 | Pages: 1-11

10.1097/dbp.0000000000000358 | PMID 27902544 Get It

ABSTRACT Objective: Previous research on the developmental course of attention-deficit/hyperactivity disorder (ADHD) is limited by biased clinic-referred samples and other methodological problems. Thus, questions about adult academic outcomes associated with childhood ADHD remain unanswered. Thus, the objective of this study was to describe academic outcomes in adulthood among incident cases of research-identified childhood ADHD versus non-ADHD referents from a population-based birth cohort. Method: Young adults with research-identified childhood ADHD (N = 232; mean age 27.0 yr; 72.0% men) and referents (N = 335; mean age 28.6 yr; 62.7% men) from a 1976 to 1982 birth cohort (N = 5699) were invited to participate in a followup study and were administered an academic achievement battery consisting of the basic reading component of the Woodcock-Johnson III Tests of Achievement (WJ-III) and the arithmetic subtest of the Wide Range Achievement Test—Third Edition (WRAT-3). Outcomes were compared between the 2 groups using linear regression models, adjusted for age, sex, and comorbid learning disability status. Results: Childhood ADHD cases scored from 3 to 5 grade equivalents lower on all academic tests compared with referents, with mean (SD) standard scores of 95.7 (8.4) versus 101.8 (8.1) in basic reading; 95.0 (9.3) versus 101.9 (8.5) in letterword identification; 98.2 (8.6) versus 103.2 (9.2) in passage comprehension; 95.7 (9.1) versus 100.9 (9.0) in word attack; and 87.8 (12.9) versus 98.0 (12.0) in arithmetic. Conclusion: This is the first prospective, population-based study of adult academic outcomes of childhood ADHD. Our data provide evidence that childhood onset ADHD is associated with long-term underachievement in reading and math that may negatively impact ultimate educational attainment and occupational functioning in adulthood.
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Tefferi, Ayalew , Finke, Christy M. , Rotunno, Giada, Elala, Yoseph, Pacilli, Annalisa , Hanson, Curtis A. , Pancrazzi, Alessandro , Mannarelli, Carmela, Barraco, Daniela , Fanelli, Tiziana , Pardanani, Animesh , Gangat, Naseema , Lasho, Terra L. , Guglielmelli, Paola , Ketterling, Rhett P. , Vannucchi, Alessandro M.

Blood Advances | November 30, 2016 | Volume: 1 | Issue: 1 | Pages: 21-30

10.1182/bloodadvances.2016000216 | PMID 29296692 Get It

Key Points More than half of patients with PV or ET harbor DNA mutations/variants other than JAK2/CALR/MPL. The presence of some of these mutations adversely affects overall, leukemia-free, or myelofibrosis-free survival.
Targeted deep sequencing in primary myelofibrosis
Tefferi, Ayalew , Finke, Christy M. , Elala, Yoseph, Hanson, Curtis A. , Gangat, Naseema , Pardanani, Animesh , Lasho, Terra L. , Ketterling, Rhett P.

Blood Advances | November 30, 2016 | Volume: 1 | Issue: 2 | Pages: 105-111

10.1182/bloodadvances.2016000208 | PMID 29296803 Get It

Key Points More than 80% of patients with PMF harbor DNA variants/mutations other than JAK2/CALR/MPL. Some of these variants/mutations adversely affect overall or leukemia-free survival independent of conventional risk stratification.
Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse
Cranmer, Lee D. , Larsen, Brandon T. , Kuo, Phillip H. , Kopp, Lisa M. , Liu, Julia, Liu, Julia C. , Kopp, Lisa

Journal of Pediatric Hematology/Oncology | November 30, 2016 | Volume: 39 | Issue: 4 | Pages: 302-305

10.1097/mph.0000000000000719 | PMID 27906792 Get It

Osteosarcoma (OS) is a malignant bone tumor which is found primarily in adolescents, with the distal femur as the most common location. OS with a jaw primary is present in only about 10% of cases and the risk of recurrence is considered to be decreased in the jaw versus other primary locations. We present a unique case of a patient with localized OS of the jaw with an isolated recurrence in her bone marrow almost 5 years after completion of initial treatment.
How Asking about the Best Ice Cream Reveals Ourselves
Ng, J. , NG, JENNIFER

Ethnographic Praxis in Industry Conference Proceedings | November 30, 2016 | Volume: 2016 | Issue: 1 | Pages: 550-550

10.1111/1559-8918.2016.01124 Get It

As an author of a book about ice cream around the world, I am often asked this question: What is the best ice cream? I am often stumped. I know that they want something that they don't know from the “expert”. So when I hesitantly answer, I would give my personal favorite, one that I discovered during my travels—a goat cheese ice cream with roasted cherries from Jeni's Ice Cream in Columbus, Ohio.Yet I was curious—why do people ask that question if it could be potentially disappointing? Do they really want the #1 based on my personal opinion? Did they want to find something new to try? Were they trying to understand my motivation? Were they curious about a story? I unravel this question through an investigation of the intention of the question. When applied to ethnography, how does that question apply? As ethnographers, do we miss an important insight if we don't ask about the best?
Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia
Marnach, Mary L. , Butler, Kristina , Henry, Michael , Hutz, Catherine E., Lohse, Christine M. , Casey, Petra M., Butler, Kristina A., Henry, Michael R, Langstraat, Carrie

Journal of Women's Health | November 30, 2016 | Volume: 26 | Issue: 4 | Pages: 368-373

10.1089/jwh.2016.5774 | PMID 27901412 Get It

Detection of Parenchymal Abnormalities in Experimentally Induced Acute Pyelonephritis in Rabbits Using Contrast-Enhanced Ultrasonography, CT, and MRI
Kim, Seung Kwon , Seo, Jin Won , Ryu, Jeong Ah , Kim, Bohyun , Kim, Jong-Sung

Journal of the Korean Society of Radiology | November 30, 2016 | Volume: 75 | Issue: 6 | Pages: 487

10.3348/jksr.2016.75.6.487 Get It

Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012
Padrnos, Leslie , Karlin, Nina J. , Hálfdánarson, Þorvarður R. , Karlin, Nina, Halfdanarson, Thorvardur R

Rare Tumors | November 30, 2016 | Volume: 8 | Issue: 4 | Pages: 142-145

10.4081/rt.2016.6804 | PMID 27994832 Get It

Extramammary Paget disease (EMPD) is a rare cutaneous malignancy. The most common presentation of EMPD is the vulva followed by perianal involvement. Most cases are localized to the dermis with treatment focused on surgery, topical treatment or radiotherapy. Recurrence is frequent despite therapies utilized. Metastatic extramammary Paget disease is uncommon and, as such, standard treatment guidelines do not exist. This study sought to evaluate the treatment regimens and outcomes of patients treated at a Mayo Clinic Center from 1998-2012. Cancer registry inquiry revealed 261 patients with report advanced Paget disease during these years. Ten cases of metastatic EPMD were identified with sufficient documentation for review. This review reveals support for utilizing localized radiation therapy for bulky disease sequentially with systemic chemotherapy consisting of carboplatin and paclitaxel or irinotecan. Further studies are necessary to define the optimal treatment regimen.